The country with the highest rate of malaria deaths in the world has approved Oxford's vaccineByFaustine NgilaPublishedApril 18, 2023
Merck is paying $10.8 billion for a company with no approved drugsByAnanya BhattacharyaPublishedApril 17, 2023
J&J quadrupled its initial offer to settle cancer lawsuits over its talc-based baby powderByAnanya BhattacharyaPublishedApril 5, 2023
A Texas ruling threatens to take away several free preventive health services for AmericansByAnnalisa MerelliPublishedMarch 31, 2023
Medicaid's continuous enrollment ends today. Up to 14 million Americans could lose their coverageByAnnalisa MerelliPublishedMarch 31, 2023
The FDA will no longer approve digital medical devices that are vulnerable to cyber attacksByAnnalisa MerelliPublishedMarch 30, 2023
The WHO will consider adding obesity drugs to the list of essential medicinesByAnnalisa MerelliPublishedMarch 29, 2023
Narcan is finally approved to be sold over the counter in the USByAnnalisa MerelliPublishedMarch 29, 2023
A former FDA official testified how the agency failed to prevent a baby formula shortageByAnnalisa MerelliPublishedMarch 29, 2023
As Covid-19 shot sales dwindle, BioNTech doubles down on cancer vaccinesByAnnalisa MerelliUpdatedMarch 27, 2023
Switzerland is giving weed a try as cannabis legalization gains steam in EuropeByClarisa DiazPublishedMarch 23, 2023
The price of Humira's biosimilars can uncloak the secret villain of US drug pricingByAnnalisa MerelliPublishedMarch 23, 2023
Rich countries are all set to hoard bird flu vaccines that don't even exist yetByAnnalisa MerelliPublishedMarch 22, 2023
How Scotland cut alcohol-related deaths by 13% in less than three yearsByCassie WerberPublishedMarch 21, 2023
India is among the least happy countries in the world—worse than even war-hit UkraineByMimansa VermaPublishedMarch 21, 2023
More American women over 40 are having babies. Their risk of dying from it keeps rising tooByAnnalisa MerelliPublishedMarch 17, 2023
